CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.8300
+0.1040 (14.33%)
At close: Mar 13, 2026, 4:00 PM EDT
0.8300
0.00 (0.00%)
Pre-market: Mar 16, 2026, 4:53 AM EDT
CalciMedica Market Cap
CalciMedica has a market cap or net worth of $13.07 million as of March 16, 2026. Its market cap has decreased by -57.49% in one year.
Market Cap
13.07M
Enterprise Value
9.75M
1-Year Change
-57.49%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since March 21, 2023, CalciMedica's market cap has decreased from $18.50M to $13.07M, a decrease of -29.35%. That is a compound annual growth rate of -11.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 13.07M | -86.24% |
| Dec 31, 2025 | 94.96M | 98.97% |
| Dec 31, 2024 | 47.73M | 193.54% |
| Dec 29, 2023 | 16.26M | -12.10% |
| Mar 21, 2023 | 18.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 13.59M |
| Cellectar Biosciences | 13.57M |
| Quoin Pharmaceuticals | 13.49M |
| BioCardia | 13.37M |
| GT Biopharma | 13.08M |
| Curis | 13.01M |
| Kairos Pharma | 12.53M |
| BioLineRx | 12.50M |